Gene · 2176
Papers2,586
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,586
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Multi-Ancestry Genome-wide Association Analyses Identify Shared and Specific Genetic Architecture in Mild and Moderate-to-Severe Asthma. | medRxiv | 2026 | 42818167 | PubTator, text mining | PubMed |
| Gene by environment interaction effects on the metabolic subtype of Polycystic Ovary Syndrome in Hispanic Community Health Study/Study of Latinos. | Front Genet | 2026 | 42730305 | PubTator, text mining | PubMed |
| Structure and Dynamics of the HIV-1 Envelope Protein on the Virion Envelope. | J Am Chem Soc | 2026 | 42677561 | PubTator, text mining | PubMed |
| Uncovering Hereditary Risk: Germline Homologous Recombination Repair Variant Spectrum in a Large North Indian Cancer Cohort (INSIGHT-HRR). | JCO Glob Oncol | 2026 | 42594331 | PubTator, text mining | PubMed |
| Proposals for the #Enzian addendum and update: an international expert survey for item generation. | Facts Views Vis Obgyn | 2026 | 42533569 | PubTator, text mining | PubMed |
| Concordant high-grade glioma in monozygotic twins with germline variants in ATM, FANCC, and FANCM: a case report on combined DNA repair deficiency. | Neurooncol Adv | 2026 | 42494996 | PubTator, text mining | PubMed |
| Unlocking Sulforaphane's Potential in Friedreich Ataxia: Further Evidence from Preclinical Investigations Using Induced Pluripotent Stem Cell-Derived Sensory Neurons. | Antioxid Redox Signal | 2026 | 42473835 | PubTator, text mining | PubMed |
| Site-specific promoter hypermethylation of GPX4 in heart failure with reduced ejection fraction (HFrEF): nonlinear dose-response with hepatic and coagulation markers. | Mol Biol Rep | 2026 | 42430008 | PubTator, text mining | PubMed |
| Universal Germline Genetic Testing in a Precision Oncology and Rare Cancer Clinic: Implementation and Outcomes. | JCO Oncol Adv | 2026 | 42422224 | PubTator, text mining | PubMed |
| Proliferative ecotype determines lethal prognosis and therapeutic benefit in urothelial carcinoma. | Cancer | 2026 | 42367015 | PubTator, text mining | PubMed |
| Fanconi Anemia in Mexican Patients: Molecular Spectrum and Clinical Manifestations in a Case Series. | Int J Mol Sci | 2026 | 42123592 | PubTator, text mining | PubMed |
| Integrated Molecular Profiling Improves Subtype Classification and Reveals Inherited Susceptibility in Medulloblastoma: Insights From a Real-World Cohort. | Cancer Med | 2026 | 42056683 | PubTator, text mining | PubMed |
| Micronuclei: origins, assays, mechanisms, diseases and treatments. | Signal Transduct Target Ther | 2026 | 41888103 | PubTator, text mining | PubMed |
| Consolidation enfortumab vedotin and pembrolizumab after cisplatin induction in metastatic urothelial cancer: Outcomes of complete response and bladder preservation. | J Int Med Res | 2026 | 41885091 | PubTator, text mining | PubMed |
| A Rare Case of FANCC-Mutated Fanconi Anaemia Presenting With a Negative Chromosome Breakage Test. | Pediatr Blood Cancer | 2026 | 41840796 | PubTator, text mining | PubMed |
| miR-181d coordinates homologous recombination and anti-tumor immune responses in glioblastoma. | iScience | 2026 | 41809040 | PubTator, text mining | PubMed |
| Prognostic Significance of DNA Repair Gene mRNA Expression in Early-Stage Breast Cancer: Insights into Clinical Relevance. | Oncol Res | 2026 | 41799499 | PubTator, text mining | PubMed |
| Studies and analysis of drug-target interactions by affinity chromatography and related techniques: A review. | J Pharm Anal | 2026 | 41798072 | PubTator, text mining | PubMed |
| Detection of germline variants in human population chronically exposed to high level natural background radiation in Kerala coast. | Genes Environ | 2026 | 41761368 | PubTator, text mining | PubMed |
| Genome-wide association study meta-analysis identifies susceptibility loci informing Ewing sarcoma etiology and potential mechanisms of risk. | medRxiv | 2026 | 41728338 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2176/papers